Universal driving restrictions beyond 4 weeks appear unnecessary following CAR-T therapy in multiple myeloma

• Rahul Banerjee,
• Alicia Richards,
• Shonali Midha,
• Aimaz Afrough,
• Faiz Anwer,
• Djordje Atanackovic,
• Shebli Atrash,
• Veronika Bachanova,
• Amer M. Beitinjaneh,
• Evguenia Bhurtel,
• Omar Castaneda Puglianini,
• Saurabh Chhabra,
• Kara I. Cicero,
• James A. Davis,
• Binod Dhakal,
• Danai Dima,
• Christopher J. Ferreri,
• Peter A. Forsberg,
• Ciara L. Freeman,
• Megan M. Herr,
• Tania Jain,
• Murali Janakiram,
• Jack Khouri,
• Mehmet H. Kocoglu,
• Anupama Kumar,
• Yuxin Liu,
• Frederick Locke,
• Joseph P. McGuirk,
• Lekha Mikkilineni,
• Omar Nadeem,
• Ricardo D. Parrondo,
• Oren Pasvolsky,
• Lauren C. Peres,
• Sneha Purvey,
• Shahzad Raza,
• Ran Reshef,
• Shambavi Richard,
• Adriana C. Rossi,
• Douglas W. Sborov,
• Leyla Shune,
• Charlotte B. Wagner,
• Saurabh S. Zanwar,
• Surbhi Sidana,
• Krina K. Patel,
• Doris K. Hansen,
• Shaji K. Kumar,
• Yi Lin,
• Thomas G. Martin,
• Peter M. Voorhees,
• Larry D. Anderson, Jr,
• Andrew J. Cowan,
• Gurbakhash Kaur

Affiliations

Rahul Banerjee

Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA; Correspondence: Rahul Banerjee, Division of Medical Oncology, Department of Medicine, Fred Hutchinson Cancer Center, 825 Eastlake Ave E, LG-650, Seattle, WA 98109;

Alicia Richards

Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL

Shonali Midha

Division of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA

Aimaz Afrough

Hematologic Malignancies and Cellular Therapy Program, Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX

Faiz Anwer

Division of Hematology and Medical Oncology, Cleveland Clinic, Lerner College of Medicine, Case Western Reserve University School of Medicine, Cleveland, OH

Djordje Atanackovic

Division of Hematology/Oncology, University of Maryland, Baltimore, MD

Shebli Atrash

Atrium Health Levine Cancer Institute, Wake Forest University School of Medicine, Charlotte, NC

Veronika Bachanova

Division of Hematology, Oncology, and Transplantation, University of Minnesota, Minneapolis, MN

Amer M. Beitinjaneh

Division of Transplantation and Cellular Therapy, University of Miami, Miami, FL

Evguenia Bhurtel

Division of Hematologic Malignancies and Cellular Therapeutics, The University of Kansas Medical Center, Westwood, KS

Omar Castaneda Puglianini

Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL

Saurabh Chhabra

Division of Hematology/Oncology, Mayo Clinic, Phoenix, AZ

Kara I. Cicero

Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA

James A. Davis

Department of Pharmacy, Medical University of South Carolina, Charleston, SC

Binod Dhakal

Division of Hematology, Medical College of Wisconsin, Milwaukee, WI

Danai Dima

Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA; Division of Hematology and Medical Oncology, Cleveland Clinic, Lerner College of Medicine, Case Western Reserve University School of Medicine, Cleveland, OH

Christopher J. Ferreri

Atrium Health Levine Cancer Institute, Wake Forest University School of Medicine, Charlotte, NC

Peter A. Forsberg

Division of Hematology/Oncology, Colorado Blood Cancer Institute, Denver, CO

Ciara L. Freeman

Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL

Megan M. Herr

Division of Transplant and Cellular Therapy, Roswell Park Comprehensive Cancer Center, Buffalo, NY

Tania Jain

Division of Hematology/Oncology, Johns Hopkins University, Baltimore, MD

Murali Janakiram

Department of Hematology & Hematopoietic Cell Transplantation, City of Hope Cancer Center, Duarte, CA

Jack Khouri

Division of Hematology and Medical Oncology, Cleveland Clinic, Lerner College of Medicine, Case Western Reserve University School of Medicine, Cleveland, OH

Mehmet H. Kocoglu

Division of Hematology/Oncology, University of Maryland, Baltimore, MD

Anupama Kumar

Division of Hematology/Oncology, University of California San Francisco, San Francisco, CA

Yuxin Liu

Division of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA

Frederick Locke

Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL

Joseph P. McGuirk

Division of Hematologic Malignancies and Cellular Therapeutics, The University of Kansas Medical Center, Westwood, KS

Lekha Mikkilineni

Division of Transplantation and Cell Therapy, Stanford Cancer Center, Palo Alto, CA

Omar Nadeem

Division of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA

Ricardo D. Parrondo

Division of Hematology/Oncology, Mayo Clinic, Jacksonville, FL

Oren Pasvolsky

Department of Lymphoma Myeloma, MD Anderson Cancer Center, Houston, TX

Lauren C. Peres

Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL

Sneha Purvey

Division of Hematology/Oncology, Virginia Commonwealth University, Richmond, VA

Shahzad Raza

Division of Hematology and Medical Oncology, Cleveland Clinic, Lerner College of Medicine, Case Western Reserve University School of Medicine, Cleveland, OH

Ran Reshef

Division of Hematology/Oncology, Columbia Irving Medical Center, New York City, NY

Shambavi Richard

Division of Hematology and Medical Oncology, Mount Sinai Tisch Cancer Center, New York City, NY

Adriana C. Rossi

Division of Hematology and Medical Oncology, Mount Sinai Tisch Cancer Center, New York City, NY

Douglas W. Sborov

Division of Hematology/Oncology, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT

Leyla Shune

Division of Hematologic Malignancies and Cellular Therapeutics, The University of Kansas Medical Center, Westwood, KS

Charlotte B. Wagner

Division of Hematology/Oncology, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT

Saurabh S. Zanwar

Division of Hematology/Oncology, Mayo Clinic, Rochester, MN

Surbhi Sidana

Division of Transplantation and Cell Therapy, Stanford Cancer Center, Palo Alto, CA

Krina K. Patel

Department of Lymphoma Myeloma, MD Anderson Cancer Center, Houston, TX

Doris K. Hansen

Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL

Shaji K. Kumar

Division of Hematology/Oncology, Mayo Clinic, Rochester, MN

Yi Lin

Division of Hematology/Oncology, Mayo Clinic, Rochester, MN

Thomas G. Martin

Division of Hematology/Oncology, University of California San Francisco, San Francisco, CA

Peter M. Voorhees

Atrium Health Levine Cancer Institute, Wake Forest University School of Medicine, Charlotte, NC

Larry D. Anderson, Jr

Hematologic Malignancies and Cellular Therapy Program, Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX

Andrew J. Cowan

Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA

Gurbakhash Kaur

Division of Hematology and Medical Oncology, Mount Sinai Tisch Cancer Center, New York City, NY